Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review

BRCA1andBRCA2genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance

(2015) D. M. Eccles et al.   ANNALS OF ONCOLOGY

Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement

(2015) Maria Teresa Ricci et al.   Public Health Genomics

Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

(2014) Francisco J. Candido-dos-Reis et al.   CLINICAL CANCER RESEARCH

Effects of BRCA1- and BRCA2-Related Mutations on Ovarian and Breast Cancer Survival: A Meta-analysis

(2014) Q. Zhong et al.   CLINICAL CANCER RESEARCH

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population

(2014) H. Song et al.   HUMAN MOLECULAR GENETICS

BRCA1/2 Mutation Status Is an Independent Factor of Improved Survival for Advanced (Stage III–IV) Ovarian Cancer

(2014) Vilius Rudaitis et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses

(2014) Jung-Min Lee et al.   JNCI-Journal of the National Cancer Institute

Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status

(2014) J. M. Cunningham et al.   Scientific Reports

Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) J. A. Ledermann et al.   ANNALS OF ONCOLOGY

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies

(2013) J.-m. Lee et al.   ANNALS OF ONCOLOGY

Olaparib: a promising PARP inhibitor in ovarian cancer therapy

(2013) Ying Chen et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

(2013) Kathryn P. Pennington et al.   CLINICAL CANCER RESEARCH

BRCA1 and BRCA2 Mutations in the Ovarian Cancer Population across Race and Ethnicity: Special Reference to Asia

(2013) Santhanam Shanmughapriya et al.   ONCOLOGY

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

(2013) Alexandra V. Stavropoulou et al.   PLoS One

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2

(2012) John R. McLaughlin et al.   JNCI-Journal of the National Cancer Institute

High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations

(2012) Iwona K. Rzepecka et al.   Cancer Genetics

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

(2011) Shiyu Zhang et al.   GYNECOLOGIC ONCOLOGY

Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors

(2011) Bronson D. Riley et al.   Journal of Genetic Counseling

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis

(2010) S. Iodice et al.   EUROPEAN JOURNAL OF CANCER

Tubal ligation and the risk of ovarian cancer: review and meta-analysis

(2010) D. Cibula et al.   HUMAN REPRODUCTION UPDATE

Moving Toward Personalized Medicine

(2010) Alison H. Trainer et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

(2010) Sandhya Pruthi et al.   MAYO CLINIC PROCEEDINGS

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

(2009) Allison W Kurian   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer

(2009) Molly S Daniels et al.   GENETICS IN MEDICINE

Hormone Therapy and Ovarian Cancer

(2009) Lina Steinrud Mørch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Taxanes as primary chemotherapy for early breast cancer

(2008) Federica Cuppone et al.   CANCER

BRCA1 and BRCA2 Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark

(2008) M. Soegaard et al.   CLINICAL CANCER RESEARCH

Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study

(2008) Kelly A. Metcalfe et al.   GYNECOLOGIC ONCOLOGY

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

(2008) David S.P. Tan et al.   JOURNAL OF CLINICAL ONCOLOGY

Infertility as a Cancer Risk Factor – A Review

(2008) I. Cetin et al.   PLACENTA

High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland

(2007) Izabela Brozek et al.   GYNECOLOGIC ONCOLOGY